Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Explore this paper's citation graph

Summary

Patients treated in the EMGT had half of the progression risk of control patients, including the effect of EMGT treatment, and the magnitude of initial IOP reduction was a major factor influencing outcome.

Type
article
Published
2003-07-01
Cited by
2,153
References
58
Access
Open access

Keywords

Medicine, Glaucoma, Hazard ratio, Confidence interval, Proportional hazards model

References

Cited by

Related papers